ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

theramex ireland limited - nomegestrol acetatas, estradiolio - kontracepcija - lytiniai hormonai ir moduliatoriai lytinių organų sistemos, - oral contraception,.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

astrazeneca ab - metforminas hidrochloridas, dapagliflozin propandiolis monohidratas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - xigduo yra nurodyta suaugusiesiems gydyti 2 tipo cukrinis diabetas, kaip papildoma priemonė kartu su dieta ir mankšta:• pacientams, nepakankamai kontroliuojama, jų maksimaliai toleruojama dozė vien tik metforminas • kartu su kitais vaistais gydyti cukriniu diabetu pacientams, nepakankamai kontroliuojami su metforminas ir šių vaistų• pacientams, kurie jau gydomi derinys dapagliflozin ir metforminas kaip atskiros tabletės. studijų rezultatų atžvilgiu derinys terapija, poveikis glycaemic kontroliuoti širdies ir kraujagyslių įvykių, gyventojų, studijavo, žr. skirsnius 4. 4, 4. 5 ir 5.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ir 5. 1, jei yra duomenų apie skirtingus derinius).

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

takeda pharma a/s - fentanilio citratas - pain; cancer - analgetikai - instanyl skiriamas suaugusiems pacientams, kuriems jau yra gydomasis gydymas opioidiniais vaistais nuo lėtinio vėžio skausmo. proverbinis skausmas yra trumpalaikis skausmo paūmėjimas, pasireiškiantis kitaip kontroliuojamo nuolatinio skausmo fone.  patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

astrazeneca ab  - metforminas hidrochloridas, saxagliptin hidrochloridas - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - komboglyze skiriamas kartu su dieta ir pagerinti glikemijos kontrolę sergantiems suaugusiesiems nuo 18 metų amžiaus ir vyresni 2 tipo cukriniu diabetu sergantiems glikemija kontroliuojama jų toleruojamą vien metforminu arba kurių jau yra su saksagliptinas ir metforminu atskiromis tabletėmis. komboglyze taip pat nurodė, kartu su insulino (i. trigubas derinys terapija), kaip papildoma priemonė kartu su dieta ir mankšta pagerinti glycaemic kontrolės suaugusių pacientų, vyresnių kaip 18 metų ir vyresnio amžiaus, su 2 tipo cukriniu diabetu, kai insulino ir metforminas vien nesuteikia pakankamos kontrolės glycaemic.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - cukrinis diabetas, 2 tipas - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - lytiniai hormonai ir moduliatoriai lytinių organų sistemos, - geriamoji kontracepcija. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - pioglitazone, metforminas hidrochloridas - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

ইউরোপীয় ইউনিয়ন - লিথুয়েনীয় - EMA (European Medicines Agency)

bavarian nordic a/s - vibrio cholerae, kamienas, širdies ir kraujagyslių 103-hgr, gyventi - cholera - vakcinos - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. Šios vakcinos turėtų būti naudojami laikantis oficialių rekomendacijų.